Sophia Genetics SA

NASDAQ SOPH

Data sourced from

and

Daily

Download Data

Sophia Genetics SA Market Capitalization on June 03, 2024: USD 362.83 M

Sophia Genetics SA Market Capitalization is USD 362.83 M on June 03, 2024, a 34.46% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.

Sophia Genetics SA 52-week high Market Capitalization is USD 371.82 M on March 05, 2024, which is 2.48% above the current Market Capitalization.
Sophia Genetics SA 52-week low Market Capitalization is USD 149.80 M on August 17, 2023, which is -58.71% below the current Market Capitalization.
Sophia Genetics SA average Market Capitalization for the last 52 weeks is USD 265.26 M.

NASDAQ: SOPH

Sophia Genetics SA

CEO	Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date	July 23, 2021
Location	Switzerland
Headquarters	Rue du Centre 172, Saint-Sulpice, Switzerland, 1025
Employees	430
Sector	Healthcare
Industry	Health information services

Description

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Key trends